NRX Pharmaceuticals, Inc. (NRXP)
3.67
+0.22
(+6.38%)
USD |
NASDAQ |
Aug 25, 16:00
NRX Pharmaceuticals Market Cap : 158.39M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 158.39M |
| August 24, 2026 | 148.89M |
| August 21, 2026 | 153.64M |
| August 20, 2026 | 151.48M |
| August 19, 2026 | 143.72M |
| August 18, 2026 | 148.46M |
| August 17, 2026 | 148.03M |
| August 14, 2026 | 141.13M |
| August 13, 2026 | 144.15M |
| August 12, 2026 | 145.01M |
| August 11, 2026 | 146.74M |
| August 10, 2026 | 112.13M |
| August 07, 2026 | 119.83M |
| August 06, 2026 | 103.43M |
| August 05, 2026 | 102.25M |
| August 04, 2026 | 102.09M |
| August 03, 2026 | 108.45M |
| July 31, 2026 | 105.43M |
| July 30, 2026 | 104.43M |
| July 29, 2026 | 108.11M |
| July 28, 2026 | 118.49M |
| July 27, 2026 | 121.50M |
| July 24, 2026 | 125.52M |
| July 23, 2026 | 137.57M |
| July 22, 2026 | 149.95M |
| Date | Value |
|---|---|
| July 21, 2026 | 149.28M |
| July 20, 2026 | 139.91M |
| July 17, 2026 | 142.92M |
| July 16, 2026 | 141.92M |
| July 15, 2026 | 149.28M |
| July 14, 2026 | 144.93M |
| July 13, 2026 | 138.91M |
| July 10, 2026 | 140.24M |
| July 09, 2026 | 137.57M |
| July 08, 2026 | 131.21M |
| July 07, 2026 | 139.24M |
| July 06, 2026 | 132.04M |
| July 02, 2026 | 129.53M |
| July 01, 2026 | 129.20M |
| June 30, 2026 | 136.90M |
| June 29, 2026 | 133.89M |
| June 26, 2026 | 124.85M |
| June 25, 2026 | 119.16M |
| June 24, 2026 | 119.16M |
| June 23, 2026 | 125.85M |
| June 22, 2026 | 130.54M |
| June 18, 2026 | 132.88M |
| June 17, 2026 | 133.22M |
| June 16, 2026 | 132.88M |
| June 15, 2026 | 136.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.161T |
| Pfizer Inc. | 162.82B |
| Oramed Pharmaceuticals, Inc. | 215.25M |
| Yarrow Bioscience, Inc. | 26.23M |
| ANI Pharmaceuticals, Inc. | 1.738B |
Market Cap Related Metrics
| PS Ratio | 33.50 |
| Price | 3.67 |
| Earnings Yield | -20.07% |